Article ; Online: Cell-Specific Actions of the Prostaglandin E-Prostanoid Receptor 4 Attenuating Hypertension: A Dominant Role for Kidney Epithelial Cells Compared With Macrophages.
Journal of the American Heart Association
2022 Volume 11, Issue 19, Page(s) e026581
Abstract: Background A beneficial role for prostanoids in hypertension is suggested by clinical studies showing nonsteroidal anti-inflammatory drugs, which block the production of all prostanoids, cause sodium retention and exacerbate hypertension. Among ... ...
Abstract | Background A beneficial role for prostanoids in hypertension is suggested by clinical studies showing nonsteroidal anti-inflammatory drugs, which block the production of all prostanoids, cause sodium retention and exacerbate hypertension. Among prostanoids, prostaglandin E2 and its E-prostanoid receptor 4 receptor (EP4R) have been implicated in blood pressure control. Our previous study found that conditional deletion of EP4R from all tissues in adult mice exacerbates angiotensin II-dependent hypertension, suggesting a powerful effect of EP4R to resist blood pressure elevation. We also found that elimination of EP4R from vascular smooth muscle cells did not affect the severity of hypertension, suggesting nonvascular targets of prostaglandin E mediate this antihypertensive effect. Methods and Results Here we generated mice with cell-specific deletion of EP4R from macrophage-specific EP4 receptor knockouts or kidney epithelial cells (KEKO) to assess the contributions of EP4R in these cells to hypertension pathogenesis. Macrophage-specific EP4 receptor knockouts showed similar blood pressure responses to alterations in dietary sodium or chronic angiotensin II infusion as Controls. By contrast, angiotensin II-dependent hypertension was significantly augmented in KEKOs (mean arterial pressure: 146±3 mm Hg) compared with Controls (137±4 mm Hg; |
---|---|
MeSH term(s) | Amiloride/therapeutic use ; Angiotensin II/metabolism ; Animals ; Anti-Inflammatory Agents/therapeutic use ; Antihypertensive Agents/therapeutic use ; Dinoprostone/metabolism ; Epithelial Cells ; Epithelial Sodium Channels/genetics ; Hypertension/drug therapy ; Kidney ; Macrophages/metabolism ; Mice ; Prostaglandins ; Receptors, Prostaglandin E, EP4 Subtype/genetics ; Receptors, Prostaglandin E, EP4 Subtype/metabolism ; Sodium/metabolism ; Sodium Chloride, Dietary/metabolism |
Chemical Substances | Anti-Inflammatory Agents ; Antihypertensive Agents ; Epithelial Sodium Channels ; Prostaglandins ; Receptors, Prostaglandin E, EP4 Subtype ; Sodium Chloride, Dietary ; Angiotensin II (11128-99-7) ; Amiloride (7DZO8EB0Z3) ; Sodium (9NEZ333N27) ; Dinoprostone (K7Q1JQR04M) |
Language | English |
Publishing date | 2022-09-29 |
Publishing country | England |
Document type | Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S. |
ZDB-ID | 2653953-6 |
ISSN | 2047-9980 ; 2047-9980 |
ISSN (online) | 2047-9980 |
ISSN | 2047-9980 |
DOI | 10.1161/JAHA.122.026581 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.